Immediate Impact
23 standout
Citing Papers
Antibody–Drug Conjugates (ADCs): current and future biopharmaceuticals
2025 Standout
The BCL2 family: from apoptosis mechanisms to new advances in targeted therapy
2025 Standout
Works of Domenico Viola being referenced
The Bcl‐2 inhibitor venetoclax inhibits Nrf2 antioxidant pathway activation induced by hypomethylating agents in AML
2019
Daratumumab induces CD38 internalization and impairs myeloma cell adhesion
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Domenico Viola | 48 | 43 | 86 | 76 | 54 | 27 | 328 | |
| Stavroula Kostaridou | 25 | 13 | 153 | 39 | 25 | 29 | 357 | |
| Donald M. Hayes | 44 | 77 | 94 | 71 | 22 | 21 | 286 | |
| C.S. Kwon | 15 | 35 | 58 | 86 | 45 | 21 | 345 | |
| A. Cooper | 33 | 133 | 17 | 58 | 67 | 25 | 368 | |
| Q. Meulders | 27 | 22 | 79 | 54 | 96 | 18 | 328 | |
| Soichiro Hasegawa | 14 | 112 | 61 | 25 | 38 | 34 | 334 | |
| María L. Picazo | 134 | 37 | 28 | 42 | 100 | 26 | 357 | |
| Ali Avcı | 42 | 84 | 31 | 45 | 26 | 21 | 336 | |
| J.M. Andrieu | 68 | 46 | 50 | 34 | 33 | 32 | 269 | |
| Kiyohide Toki | 17 | 29 | 14 | 83 | 71 | 30 | 319 |
All Works
Loading papers...